CELYAD ONCOLOGY SA Return On Plan Assets Net Defined Benefit Liability Asset
CELYAD ONCOLOGY SA reported Return On Plan Assets Net Defined Benefit Liability Asset of EUR 2.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-23.
Discontinued › Notes
ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset · last filed 2023-03-23
| Period end | Return On Plan Assets Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2022-12-31 | 2.00K EUR 20-F · filed 2023-03-23 |
| 2021-12-31 | -36.00K EUR 20-F · filed 2023-03-23 |
| 2020-12-31 | -14.00K EUR 20-F · filed 2023-03-23 |
| 2019-12-31 | 8.00K EUR 20-F · filed 2022-03-24 |
| 2018-12-31 | -9.00K EUR 20-F · filed 2021-03-24 |
| 2017-12-31 | -5.00K EUR 20-F · filed 2019-04-05 |
| 2016-12-31 | 1.00K EUR 20-F · filed 2018-04-06 |